Nombre del Modulo |
1.2.1.3 Libro científico |
Titulo |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Subtitulo |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Colección |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Número de Páginas |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Edición |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
ISBN |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Pais |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Idioma |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Editorial |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Tiraje |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Fecha de Aceptación |
0000-00-00 |
Fecha de Publicación |
0000-00-00 |
Coautores |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Año de la Actividad |
2011 |
Observaciones |
A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to |
Proyecto de Investigacion Asignado |
|